Vasodilator Therapy of Cardiac Failure

New England Journal of Medicine

Volumn 297, Issue 1, 1977, Pages 27-31

  Koch Weser, Jan ^a   Cohn, Jay N ^b   Franciosa, Joseph A ^b  

^a Veterans Administration Hospital ^*

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; HEXAMETHONIUM; HYDRALAZINE; ISOSORBIDE; MINOXIDIL; NITROPRUSSIDE SODIUM; PHENTOLAMINE; PRAZOSIN; TRIMAZOSIN; VASODILATOR AGENT;

CLINICAL STUDY; DRUG THERAPY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; THERAPY; VASCULAR RESISTANCE; VASODILATATION;

BLOOD VESSELS; DIURETICS; HEART FAILURE, CONGESTIVE; HEART VENTRICLE; HEMODYNAMICS; HUMAN; HYDRALAZINE; NITRATES; NITROGLYCERIN; NITROPRUSSIDE; PHENTOLAMINE; TRIMETHAPHAN; VASODILATOR AGENTS;

EID: 0017404559     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197707072970105     Document Type: Review

References (31)

1. Imperial ES, Levy MN, Zieske H Jr: Outflow resistance as an independent determinant of cardiac performance. Circ Res 9: 1148–1155, 1961
2. Sonnenblick EH, Downing SE: Afterload as a primary determinant of ventricular performance. Am J Physiol 204: 604–610, 1963
3. Cohn JN: Blood pressure and cardiac performance. Am J Med 55: 351–361, 1973
4. Cohn: Vasodilator therapy for heart failure: the influence of impedance on left ventricular performance. Circulation 48: 5–8, 1973
5. Franciosa JA, Akhtar N, Notargiacomo AV, et al: Hemodynamic and metabolic response to nitroprusside infusion in experimental acute myocardial infarction. Circulation 48: Suppl 4: IV–165, 1973
6. Aviado DM: The Lung Circulation. Vol II. New York, Pergamon Press, 1965, pp 593–624
7. Guyton achéal, Polizo D, Armstrong GG: Mean circulatory filling pressure measured immediately after cessation of heart pumping. Am J Physiol 179: 261–267, 1954
8. Watkins L Jr, Burton JA, Haber E, et al: The renin–angiotensin–aldosterone system in congestive failure in conscious dogs. J Clin Invest 57: 1606–1617, 1976
9. Higgins CB, Vatner SF, Eckberg DL, et al: Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 51: 715–724, 1972
10. Gifford RW Jr: Management and treatment of malignant hypertension and hypertensive emergencies, Hypertension. Edited by J Genest, E Koiw, O Kuchel. New York, McGraw-Hill, 1977, pp 1024–1038
11. Franciosa JA, Guiha NH, Limas CJ, et al: Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1: 650–657, 1972
12. Guiha NH, Cohn JN, Mikulic E, et al: Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 291: 587–592, 1974
13. Chatterjee K, Parmley WW, Swan HJC, et al: Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 48: 684–690, 1973
14. Cohn JN, Rodriguera E, Guiha NH: Left ventricular function in hypertensive heart disease, Hypertension Mechanisms and Management. Edited by G Onesti, K Kim. New York, Grune and Stratton, 1973, pp 191–197
15. Bolen JL, Alderman EL: Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 53: 879–883, 1976
16. Palmer RF, Lasseter KC: Drug therapy: sodium nitroprusside. N Engl J Med 292: 294–297, 1975
17. Nourok DS, Glassock RJ, Solomon DH, et al: Hypothyroidism following prolonged sodium nitroprusside therapy. Am J Med Sci 248: 129–138, 1964
18. Miller RR, Vismara LA, Williams DO, et al: Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure: differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Circ Res 39: 127–133, 1976
19. Kelly DT, Delgado CE, Taylor DR, et al: Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation 47: 729–735, 1973
20. Freis ED, Rose JC, Partenope EA, et al: The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium. J Clin Invest 32: 1285–1298, 1953
21. Burch GE, León-Galindo J, Cronvich JA: “New” treatment for chronic intractable congestive heart failure. Am Heart J 91: 735–746, 1976
22. Flaherty JT, Reid PR, Kelly DT, et al: Intravenous nitroglycerin in acute myocardial infarction. Circulation 51: 132–139, 1975
23. Cohn JN, Mathew KJ, Franciosa JA, et al: Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. Ann Intern Med 81: 777–780, 1974
24. Franciosa JA, Mikulic E, Cohn JN, et al: Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation 50: 1020–1024, 1974
25. Mikulic E, Franciosa JA, Cohn JN: Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure. Circulation 52: 477–482, 1975
26. Franciosa JA, Pierpont G, Cohn JN: Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. Ann Intern Med 86: 388–393, 1977
27. Chatterjee K, Parmley WW, Massie B, et al: Oral hydralazine therapy for chronic refractory heart failure. Circulation 54: 879–883, 1976
28. Franciosa JA, Cohn JN: Hemodynamic effects of trimazosin in patients with left ventricular failure. Clin Pharmacol Ther 21: 102–103, 1977
29. Franciosa JA, Guiha NH, Limas CJ, et al: Arterial pressure as a determinant of left ventricular filling pressure after acute myocardial infarction. Am J Cardiol 34: 506–512, 1974
30. Stead EA Jr: The role of the cardiac output in the mechanisms of congestive heart failure. Am J Med 6: 232–236, 1949
31. Shugoll GI, Bowen PJ, Moore JP, et al: Follow-up observations and prognosis in primary myocardial disease. Arch Intern Med 129: 67–72, 1972